Express News | Kenneth Griffin Reports 5.3% Passive Stake In Terns Pharmaceuticals As Of July 10

BenzingaJul 22 16:22 ET

Express News | Kenneth Griffin Reports 5.3% Passive Stake in Terns Pharmaceuticals as of July 10 - SEC Filing

ReutersJul 22 16:20 ET

EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'

BenzingaJul 18 16:59 ET

Form 144 | Terns Pharmaceuticals(TERN.US) Director Proposes to Sell 9.09 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Jul 15, $Terns Pharmaceuticals(TERN.US)$ Director OrbiMed Private Investments VII, LP intends to sell 976.8K shares of its common stock on Jul 15, with a total market value

Moomoo NewsJul 15 19:54 ET

Mizuho Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating

Moomoo NewsJul 12 04:32 ET · Ratings

Mizuho Securities Keeps Their Buy Rating on Terns Pharmaceuticals (TERN)

TipRanksJul 12 04:28 ET